Articles and Periodicals
The Data Subject’s Burden of Proof in Establishing the Harm Suffered and Claiming Compensation
Article by Gönenç Gürkaynak, Esq., Ceren Yıldız and Gamze Yalçın
Mondaq, November 22, 2021
"OFAC Publishes Sanctions Compliance Guidance For The Virtual Currency Industry" (Article by Gönenç Gürkaynak, Esq., Ceren Yıldız and Nazlı Gürün), Mondaq, November 17, 2021
Were you benefiting from the block exemption mechanism for vertical agreements? Make sure you double-check your market share this year…
Article by Gönenç Gürkaynak, Esq., Dilara Yeşilyaprak, Zeynep Ayata Aydoğan and Nil Zeren Özdemir
Mondaq, November 17, 2021
Turkey: Voting Rights of Shareholders in Joint Stock Companies
Turkey: Voting Rights of Shareholders in Joint Stock Companies
Article by Gönenç Gürkaynak, Esq., Nazlı Nil Yukaruç and Aybüke Eroğlu
Mondaq, November 11, 2021
International Law Office Competition and Antitrust Newsletter, November 11, 2021
Council of State clarifies standard of proof in RPM cases
Article by Gönenç Gürkaynak, Esq., Harun Gündüz and Naz Altınsoy Uçar
International Law Office Competition and Antitrust Newsletter, November 11, 2021
Competition Law Journal, Volume:20, Issue: 3, October 2021
A critical assessment of the recent proposals and reports on the regulation of digital mergers
Article by Gönenç Gürkaynak, Kansu Aydoğan Yeşilaltay and Zeynep Ayata Aydoğan
Competition Law Journal, Volume:20, Issue: 3, October 2021
Global Legal Group, November 2021
The International Comparative Legal Guide to: Cartels & Leniency
Periodical by Gönenç Gürkaynak, Esq. and Öznur İnanılır), Global Legal Group, November 2021.
This article appeared in the 15th edition of The International Comparative Legal Guide to: Cartels & Leniency; published by Global Legal Group Ltd, London (Contributing editors are Matthew Readings and Elvira Aliende Rodriguez of Shearman & Sterling LLP)
Concurrences Article: October 27, 2021
The Turkish Competition Authority imposes fines on two pharmaceutical companies for engaging in concerted practices to expand the use of Lucentis as opposed to Altuzan in treating eye diseases (Roche / Novartis)
Article by Gönenç Gürkaynak, Esq., Öznur İnanılır and Berfu Akgün
Concurrences, October 27, 2021
The Turkish Competition Board Examines Online Dating and Social Discovery Services within the Scope of its Merger Control Regime
Article by Gönenç Gürkaynak, Esq., Ali Kağan Uçar, Hakan Demirkan and Nilüfer Firik
Mondaq, October 25, 2021
UNCITRAL 2021 Expedited Arbitration Rules Entered Into Force
Article by Gönenç Gürkaynak, Esq., Ceyda Karaoğlan Nalçacı, Tuğba Uluay and Mustafa Öztürk
Mondaq, October 25, 2021